Core Viewpoint - The A-share market showed signs of recovery on December 5, with the ChiNext index rising over 1% after an initial drop of more than 0.5%. The non-bank financial sector experienced significant gains, driven by positive news regarding China Ping An and regulatory adjustments in the insurance sector [2]. Group 1: Market Performance - The A-share market rebounded, with the ChiNext index increasing by over 1% after a morning decline [2]. - The non-bank financial sector saw a collective surge in the afternoon, with notable stocks like China Ping An and China Pacific Insurance rising over 5% [2]. Group 2: Company-Specific Developments - Morgan Stanley, referred to as the "whistleblower" of the A-share market, added China Ping An to its focus list and maintained it as a top pick [2]. - Morgan Stanley raised the target price for China Ping An's A-shares from 70 yuan to 85 yuan and for its H-shares from 70 HKD to 89 HKD [2]. Group 3: Regulatory Changes - The Financial Regulatory Bureau released a notice adjusting risk factors related to insurance companies' business operations, aiming to promote high-quality development while maintaining risk control [2]. - The adjustments include changes to the risk factors for insurance companies investing in stocks and for export credit insurance, encouraging greater support for foreign trade enterprises [2].

第三，发挥投资合力，建立全谱系科技金融服务能力。科技创新具有"投入大、周期长、风险高"的 特征，不同阶段对资金期限、风险偏好和服务需求差异显著。国寿资产综合运用多元投资工具和产品形 态推进科技投资落地，目前形成了以权益投资为主、另类投资和固收投资有效补充的科技投资模式。面 向未来，国寿资产将努力打造长期价值导向的权益投资科创引擎，完善多策略广覆盖的债券投资支持体 系，构建多种工具模式互补的另类投资服务矩阵，推动形成覆盖全周期、模式多元化、能力专业化的科 技投资体系。 转自：证券日报网 本报记者 冷翠华 党的二十届四中全会明确提出"加快高水平科技自立自强，引领发展新质生产力"。中国人寿资产管 理有限公司（以下简称"国寿资产"）相关业务负责人近日在接受《证券日报》记者采访时表示，将结合 自身"耐心资本"的天然禀赋，把高水平科技自立自强融入顶层投资决策与长期发展规划，完善投研体 系，以更好地"读懂"硬核科技。同时，优化考核方式，推动保险投资更好服务科技自立自强。 战略规划更加突出科技金融 国寿资产上述业务负责人表示，该公司将着力加强对实现高水平科技自立自强的金融支持，从战略 谋划、配置理念、投资体系等关键要素入手全 ...

Core Viewpoint - The insurance sector has seen a significant rise in stock prices following the announcement of favorable policies aimed at encouraging long-term investments by insurance companies [1][5]. Group 1: Policy Adjustments - The Financial Regulatory Authority has announced a reduction in risk factors for insurance companies investing in certain stocks, specifically those held for over three years and two years, respectively [2][5]. - The risk factor for stocks in the CSI 300 index and the CSI Dividend Low Volatility 100 index has been lowered from 0.3 to 0.27 for holdings over three years [2]. - For stocks listed on the Sci-Tech Innovation Board held for over two years, the risk factor has been reduced from 0.4 to 0.36 [2]. Group 2: Implications for Insurance Companies - The reduction in risk factors means lower capital consumption for insurance companies, which will enhance their solvency ratios and provide more room for further stock purchases and investment operations [5][6]. - The adjustments are expected to benefit all insurance companies that meet the conditions for investing in the specified stocks [5]. Group 3: Industry Expectations - There has been a strong industry call for optimizing solvency policies to better support equity asset allocation, especially in a low-interest-rate environment [6][7]. - Industry insiders have suggested that the regulatory body should further refine risk factor classifications based on investment fields and holding periods to encourage long-term investments [6][7]. Group 4: Historical Context and Future Directions - The Financial Regulatory Authority has previously made several adjustments to solvency policies to guide insurance funds in supporting the capital market and the real economy [8]. - Future measures are expected to focus on enhancing the long-term investment management capabilities of insurance companies and ensuring accurate solvency data [8].

港股保险板块午后涨幅扩大，截至发稿，中国平安(02318.HK)和中国太保(02601.HK)涨6%、中国人寿 (02628.HK)涨4%。摩根士丹利今日发布研报，将中国平安 (02318.HK/601318.SH) 纳入中国内地 / 中国 香港重点关注名单，维持 "首选" 评级，同时大幅上调目标价，A股目标价从70元升至85元（+21%）， H股目标价从70港元升至89港元（+27%）。大摩相信中国平安可以抓住居民理财、医疗健康和养老领 域的关键增长机会。同时，市场的主要担忧正在逐步出清，为该公司估值提升铺平道路。 ...

12月5日金融一线消息，保险股持续拉升，中国太保涨超7%，中国平安涨超5%，中国人保、中国人寿 等跟涨。 责任编辑：秦艺 责任编辑：秦艺 12月5日金融一线消息，保险股持续拉升，中国太保涨超7%，中国平安涨超5%，中国人保、中国人寿 等跟涨。 ...

Core Viewpoint - Hong Kong insurance stocks experienced a significant rally in the afternoon, with notable increases in share prices for major companies in the sector [1] Group 1: Company Performance - China Ping An (02318.HK) saw its stock price rise by over 5% [1] - China Taiping (00966.HK) recorded an increase of nearly 4% [1] - Other companies such as China Pacific Insurance (02601.HK) and China Life (02628.HK) also experienced upward movement in their stock prices [1]

Group 1: Hong Kong IPO Market Overview - In November 2025, the Hong Kong Stock Exchange saw 12 companies successfully listed, raising approximately HKD 40.401 billion, marking the third-highest fundraising scale of the year [1] - The leading sectors for fundraising included automotive manufacturing, autonomous driving, biotechnology, and software services, indicating strong international capital confidence in China's leading enterprises in new energy and AI [2][4] - Notable contributions to the fundraising total came from companies such as Seres (HKD 14.283 billion), Pony.ai (HKD 6.707 billion), and Innovation International (HKD 5.495 billion), which together accounted for over 65.56% of the total [2] Group 2: Upcoming IPOs and Market Activity - A total of 55 companies submitted IPO applications in November, with 11 companies initiating their offering process, indicating a robust pipeline for future listings [7] - The market is expected to remain active, supported by high-quality projects from companies like JD Industrial, Tianyu Semiconductor, and Naxin Microelectronics, which are anticipated to contribute to the IPO landscape in late 2025 and early 2026 [7] Group 3: US IPO Market Insights - In the US market, no Chinese companies completed IPOs in November due to the government shutdown affecting the SEC's operations, which led to a slowdown in the review process for new IPO applications [8][10] - Despite the lack of new listings, seven companies submitted IPO applications, primarily in logistics, digital marketing, and tourism services, showcasing the ongoing interest of Chinese firms in the US market [10] Group 4: Regulatory Developments and Efficiency - Sixteen companies received approval from the China Securities Regulatory Commission for overseas listings, surpassing the previous month's figures and setting a new record for 2025 [12] - The average approval time for these projects was approximately five months, reflecting improved efficiency and predictability in the regulatory process, which enhances corporate confidence in pursuing overseas listings [12] Group 5: Market Outlook - The Hong Kong market is expected to maintain its status as a preferred destination for Chinese companies seeking to list abroad, supported by a clear focus on hard technology and substantial fundraising capabilities [13] - The ongoing regulatory improvements and the active pipeline of companies indicate a promising future for both the Hong Kong and US IPO markets, with potential for a return of Chinese enterprises to the US when conditions are favorable [13]

Group 1 - The core point of the announcement is that China Life Insurance Co., Ltd. will act as a sales agent for certain open-end funds managed by CCB Fund Management Co., Ltd. starting from December 5, 2025 [1][3] - The applicable funds for this sales agreement have not been specified in the announcement [1] - Investors can consult details through China Life's customer service at 95519 or visit their website, as well as through CCB Fund's customer service at 400-81-95533 and their website [1]

Core Viewpoint - China Life Insurance (02628) shows signs of stabilization in its stock price, currently at HKD 26.68, with a rise of 1.37% [1] Technical Analysis - The stock price has successfully risen above the 60-day moving average (HKD 24.32) and is close to the 10-day (HKD 26.68) and 30-day (HKD 26.15) moving averages, indicating a shift from weakness to stability in the short to medium term [1] - Momentum oscillators have issued a clear "buy" signal, corroborating the stock's stabilization above key moving averages [1] - However, the Ichimoku indicator has given a "sell" signal, suggesting a divergence in market sentiment regarding future momentum [1] Resistance and Support Levels - Key resistance is identified at HKD 27.3; if surpassed, the next target is HKD 28.1 [3] - Support levels are at HKD 25.4 (first line of defense) and HKD 24.9 (strong support area) [3] Derivative Market Insights - Historical performance of derivative tools shows significant leverage; for instance, on December 2, when China Life's stock fell by 3.00%, related bearish tools saw impressive returns, with Societe Generale's bear certificates (53450) and UBS's bear certificates (53368) rising by 23% within two days [3] - This highlights how derivatives can amplify returns during clear directional movements in the underlying stock [3] Investment Options - For bullish investors, two types of call options are recommended: Morgan Stanley's call option (19256) offers low premiums and favorable implied volatility, while UBS's call option (18990) provides another low-premium choice [6] - For bearish strategies, options like Bank of China's put option (19617) and UBS's put option (19408) offer relatively low premiums, while Societe Generale's bear certificate (53181) features a low premium and over 10x leverage [8]

证券代码：601628 证券简称：中国人寿 公告编号：2025-043 中国人寿保险股份有限公司关于召开2025年第二次临时股东大会的通知 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 重要内容提示： ● 股东大会召开日期：2025年12月30日 ● 本次股东大会采用的网络投票系统：上海证券交易所股东大会网络投票系统 一、召开会议的基本情况 (一)股东大会类型和届次 2025年第二次临时股东大会 (二)股东大会召集人：董事会 (三)投票方式：本次股东大会所采用的表决方式是现场投票和网络投票相结合的方式 (四)现场会议召开的日期、时间和地点 召开的日期时间：2025年12月30日 9 点 30分 召开地点：中国北京市西城区金融大街16号中国人寿广场A座二层多功能厅 (五)网络投票的系统、起止日期和投票时间 网络投票系统：上海证券交易所股东大会网络投票系统 网络投票起止时间：自2025年12月30日 至2025年12月30日 采用上海证券交易所网络投票系统，通过交易系统投票平台的投票时间为股东大会召开当日的交易时间 段，即9:1 ...